The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Imidacloprid is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids which act on the central nervous system of insects, with much lower toxicity to mammals. The chemical works by interfering with the transmission of stimuli in the insect nervous system. Specifically, it causes a blockage of the nicotinergic neuronal pathway. By blocking nicotinic acetylcholine receptors, imidacloprid prevents acetylcholine from transmitting impulses between nerves, resulting in the insect’s paralysis and eventual death. It is effective on contact and via stomach action. Because imidacloprid binds much more strongly to insect neuron receptors than to mammal neuron receptors, this insecticide is more toxic to insects than to mammals.
This report provides detailed analysis of worldwide markets for Imidacloprid (CAS 138261-41-3) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Imidacloprid (CAS 138261-41-3) market and further lays out an analysis of the factors influencing the supply/demand for Imidacloprid (CAS 138261-41-3), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Imidacloprid (CAS 138261-41-3) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Imidacloprid (CAS 138261-41-3) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Imidacloprid (CAS 138261-41-3) market are Bayer (Germany), Atul Ltd (India), Sudarshan (India), BCIL (India), Hailir (China), Jiangsu Changlong (China), Sino-Agri United (China), Jiangsu Changqing (China), Jiangsu Kesheng (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Imidacloprid (CAS 138261-41-3) industry has been provided.